Used primarily in research and development within the pharmaceutical industry, this compound is often studied for its potential effects on the central nervous system. It may be investigated for its interactions with specific neurotransmitter systems, particularly those involving dopamine and serotonin receptors. This makes it a candidate for exploring treatments for neurological and psychiatric disorders, such as depression, anxiety, or Parkinson's disease. Additionally, it could be utilized in biochemical assays to better understand receptor binding mechanisms and signal transduction pathways. Its role in preclinical studies helps in the design and optimization of new therapeutic agents targeting brain-related conditions.